People

Michael Dustar

Mentioned in 1 analyzed podcast episode across 1 show

Appears On

Episode Appearances

The Top Line

The Top Line · Jul 10, 2026

A $10B deal, China trial scrutiny and highlights from ADA 2026

Discussed company positioning, oral obesity pill success, and confidence in Novo's market leadership at ADA

Vertex Crinetics acquisition and rare endocrine disease expansionClinical trial regulation and China data integrity scrutinyGLP-1 agonist efficacy and weight loss outcomes
View Analysis